Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOHN B BUSE

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1336164680
CMS profile
151275
Location
CHAPEL HILL, NC

General Payments · PY2018–2024

$517,037.93

  • Reported across 345 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$69,013.93

73 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $15,857.16 20
Novo Nordisk AS $13,669.49 5
Corcept Therapeutics $10,097.13 12
VERTEX PHARMACEUTICALS INCORPORATED $8,894.05 16
Eli Lilly and Company $8,393.10 12
AstraZeneca UK Limited $5,490.50 4
Novo Nordisk AS $4,250.00 1
DEXCOM, INC. $1,487.50 2
Embecta Corp. $875.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $145,137.14 68
PY2019 $100,712.39 49
PY2020 $49,736.48 35
PY2021 $54,625.00 18
PY2022 $56,357.00 40
PY2023 $41,455.99 62
PY2024 $69,013.93 73

Payment records · PY2024 (73)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $805.50 03/14/2024 Consulting Fee Undisputed 01/23/2026 1104516386 CMS
AstraZeneca Pharmaceuticals LP $501.05 06/25/2024 Travel and Lodging Undisputed 01/23/2026 1104380865 CMS
AstraZeneca Pharmaceuticals LP $104.69 06/25/2024 Food and Beverage Undisputed 01/23/2026 1104661865 CMS
AstraZeneca Pharmaceuticals LP $167.50 06/25/2024 Travel and Lodging Undisputed 01/23/2026 1104685611 CMS
AstraZeneca Pharmaceuticals LP $69.91 06/25/2024 Food and Beverage Undisputed 01/23/2026 1105228721 CMS
AstraZeneca Pharmaceuticals LP $78.93 06/25/2024 Food and Beverage Undisputed 01/23/2026 1105358562 CMS
AstraZeneca Pharmaceuticals LP $501.05 06/25/2024 Travel and Lodging Undisputed 01/23/2026 1105577084 CMS
AstraZeneca Pharmaceuticals LP $135.00 06/25/2024 Food and Beverage Undisputed 01/23/2026 1105587328 CMS
AstraZeneca Pharmaceuticals LP $96.03 06/25/2024 Food and Beverage Undisputed 01/23/2026 1105617593 CMS
AstraZeneca Pharmaceuticals LP $500.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1104371837 CMS
AstraZeneca Pharmaceuticals LP $250.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1104526924 CMS
AstraZeneca Pharmaceuticals LP $1,250.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1104644583 CMS
AstraZeneca Pharmaceuticals LP $805.50 09/18/2024 Consulting Fee Undisputed 01/23/2026 1105376898 CMS
AstraZeneca Pharmaceuticals LP $805.50 09/23/2024 Consulting Fee Undisputed 01/23/2026 1104673315 CMS
AstraZeneca Pharmaceuticals LP $805.50 10/01/2024 Consulting Fee Undisputed 01/23/2026 1104227517 CMS
AstraZeneca Pharmaceuticals LP $5,370.00 10/17/2024 Consulting Fee Undisputed 01/23/2026 1104586044 CMS
AstraZeneca Pharmaceuticals LP $537.00 11/06/2024 Consulting Fee Undisputed 01/23/2026 1105627131 CMS
AstraZeneca Pharmaceuticals LP $1,000.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1104644119 CMS
AstraZeneca Pharmaceuticals LP $1,074.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1104656729 CMS
AstraZeneca Pharmaceuticals LP $1,000.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1105811249 CMS
AstraZeneca UK Limited $2,148.00 04/04/2024 Consulting Fee Undisputed 01/23/2026 1093922384 CMS
AstraZeneca UK Limited $1,500.00 04/12/2024 Consulting Fee Undisputed 01/23/2026 1094008112 CMS
AstraZeneca UK Limited $1,342.50 04/29/2024 Consulting Fee Undisputed 01/23/2026 1093965366 CMS
AstraZeneca UK Limited $500.00 10/15/2024 Consulting Fee Undisputed 01/23/2026 1093927824 CMS
Corcept Therapeutics $56.25 01/22/2024 Education Undisputed 01/23/2026 1117786469 CMS
Corcept Therapeutics $124.01 06/21/2024 Food and Beverage Undisputed 01/23/2026 1117786501 CMS
Corcept Therapeutics $3,262.50 07/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117786499 CMS
Corcept Therapeutics $1,500.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 1117786507 CMS
Corcept Therapeutics $4,000.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1117786537 CMS
Corcept Therapeutics $286.95 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1117786539 CMS
Corcept Therapeutics $206.05 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1117786543 CMS
Corcept Therapeutics $102.20 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1117786545 CMS
Corcept Therapeutics $171.42 11/21/2024 Travel and Lodging Undisputed 01/23/2026 1117786547 CMS
Corcept Therapeutics $22.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 1117786549 CMS
Corcept Therapeutics $29.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 1117786551 CMS
Corcept Therapeutics $336.75 12/18/2024 Travel and Lodging Undisputed 01/23/2026 1117786541 CMS
Dexcom, Inc. $892.50 03/05/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1153309353 CMS
Dexcom, Inc. $595.00 04/09/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1153309351 CMS
Eli Lilly and Company $179.00 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1135030078 CMS
Eli Lilly and Company $9.99 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1135030080 CMS
Eli Lilly and Company $12.95 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1135030082 CMS
Eli Lilly and Company $35.00 03/01/2024 Food and Beverage Undisputed 01/23/2026 1135030084 CMS
Eli Lilly and Company $185.00 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1135053212 CMS
Eli Lilly and Company $14.32 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1135054738 CMS
Eli Lilly and Company $365.82 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1135070625 CMS
Eli Lilly and Company $4.99 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1135070627 CMS
Eli Lilly and Company $15.21 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1135070629 CMS
Eli Lilly and Company $30.82 03/11/2024 Travel and Lodging Undisputed 01/23/2026 1135053210 CMS
Eli Lilly and Company $40.00 03/11/2024 Travel and Lodging Undisputed 01/23/2026 1135067291 CMS
Eli Lilly and Company $7,500.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 1135070051 CMS
Embecta Corp. $875.00 02/08/2024 Consulting Fee Undisputed 01/23/2026 1144992649 CMS
Novo Nordisk AS $217.38 10/03/2024 Travel and Lodging Undisputed 01/23/2026 1096551941 CMS
Novo Nordisk AS $9,875.00 10/03/2024 Consulting Fee Undisputed 01/23/2026 1096552095 CMS
Novo Nordisk AS $379.64 10/03/2024 Food and Beverage Undisputed 01/23/2026 1096552189 CMS
Novo Nordisk AS $344.78 10/03/2024 Travel and Lodging Undisputed 01/23/2026 1096552293 CMS
Novo Nordisk AS $2,852.69 10/03/2024 Travel and Lodging Undisputed 01/23/2026 1096553187 CMS
Novo Nordisk Inc $4,250.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 1096690108 CMS
VERTEX PHARMACEUTICALS INCORPORATED $6.84 01/03/2024 Food and Beverage Undisputed 01/23/2026 1105906029 CMS
VERTEX PHARMACEUTICALS INCORPORATED $3,750.00 01/03/2024 Consulting Fee Undisputed 01/23/2026 1105907453 CMS
VERTEX PHARMACEUTICALS INCORPORATED $40.00 01/03/2024 Travel and Lodging Undisputed 01/23/2026 1105909546 CMS
VERTEX PHARMACEUTICALS INCORPORATED $26.50 01/03/2024 Travel and Lodging Undisputed 01/23/2026 1105916522 CMS
VERTEX PHARMACEUTICALS INCORPORATED $26.20 01/03/2024 Travel and Lodging Undisputed 01/23/2026 1105921305 CMS
VERTEX PHARMACEUTICALS INCORPORATED $345.88 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1105908165 CMS
VERTEX PHARMACEUTICALS INCORPORATED $301.61 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1105908167 CMS
VERTEX PHARMACEUTICALS INCORPORATED $24.00 11/15/2024 Food and Beverage Undisputed 01/23/2026 1105908878 CMS
VERTEX PHARMACEUTICALS INCORPORATED $38.50 11/15/2024 Food and Beverage Undisputed 01/23/2026 1105914404 CMS
VERTEX PHARMACEUTICALS INCORPORATED $18.50 11/15/2024 Food and Beverage Undisputed 01/23/2026 1105915802 CMS
VERTEX PHARMACEUTICALS INCORPORATED $211.11 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1105915804 CMS
VERTEX PHARMACEUTICALS INCORPORATED $23.00 11/15/2024 Food and Beverage Undisputed 01/23/2026 1105922673 CMS
VERTEX PHARMACEUTICALS INCORPORATED $23.50 12/11/2024 Travel and Lodging Undisputed 01/23/2026 1105911674 CMS
VERTEX PHARMACEUTICALS INCORPORATED $4,000.00 12/11/2024 Consulting Fee Undisputed 01/23/2026 1105915080 CMS
VERTEX PHARMACEUTICALS INCORPORATED $26.25 12/11/2024 Travel and Lodging Undisputed 01/23/2026 1105916524 CMS
VERTEX PHARMACEUTICALS INCORPORATED $32.16 12/11/2024 Travel and Lodging Undisputed 01/23/2026 1105922001 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.